Science1 publisher3 min readPublished
SUNY Upstate team finds oligodendrocytes read axon width through Piezo1 to set myelin length
SUNY Upstate researchers report in PLOS Biology that oligodendrocytes use the Piezo1 channel to sense axon width and set how long each myelin segment grows. The work covers early myelination, so using the sensor to lengthen the short sheaths in chronic multiple sclerosis lesions is still only a proposal.
The Scientist · Science desk
What happened
- Anatomists have long observed across vertebrates that thicker axons carry longer myelin segments and thinner axons carry shorter ones.
- In chronic multiple sclerosis lesions, newly rebuilt sheaths are abnormally thin and short. That can limit how far conduction speed recovers.
- Amanda R. Young was first author and Marie Bechler senior author, and the work drew on SUNY Upstate's Electron Microscopy Core.
Compiled by The ScientistSomething wrong?How this is made
Why it matters
- capability If Piezo1 still works in adult lesions, remyelination research gains a physical input for controlling sheath length. Current MS drugs mostly act by suppressing the immune system, so this would be a different kind of target.
- constraint Because the channel acts during early myelination, a Piezo1-based repair strategy first needs evidence that the channel operates on the cells rebuilding myelin in adult tissue.
- contradiction The release credits higher curvature on wider axons, yet wider cylinders are less curved. What Piezo1 actually senses has to come from the paper, not the press summary.
The press release says the team used "advanced cellular modeling," with help from SUNY Upstate's Electron Microscopy Core [3]. It does not name the species, say whether the sheaths formed on living axons or on engineered fibers, or report sheath lengths or effect sizes. Those details decide what the result rules out. To show that a cell is reading width itself, an experiment has to change width while holding the axon's other signals fixed. Then it has to show that removing Piezo1 breaks the link between width and length.
One line in the release's physical account needs checking against the paper. According to the release, a membrane wrapping a wider axon meets "increased mechanical curvature and membrane tension," and this activates Piezo1 [4]. But a wider axon is a larger cylinder, and a membrane wrapped around a cylinder curves less as the radius grows [1]. So the channel may be responding to tension, or to some other quantity that rises with width. Or the summary has the direction of curvature backwards.
The timing limits the therapeutic claim. Piezo1 does its work early in myelination, while the cell is still sampling the axon and extending membrane along it, before the sheath settles into its mature form [5]. The release presents the finding as "a biological blueprint" for regrowing myelin in conditions such as multiple sclerosis [8]. In chronic MS lesions, newly remyelinated sheaths are abnormally thin and short, and that can hold back recovery of conduction speed [7]. Current MS drugs mostly suppress the immune attack, and according to the release, restoring myelin is still a major hurdle [6].
A sensor that sets length during development could help with that problem only if it is still present and working on the cells that rebuild myelin in adult lesions. Showing that would take a different study from the developmental one the release describes [5].
Marie Bechler, the senior author, puts the lab's aims in those terms. "Numerous neurological conditions across our lifespan disrupt oligodendrocyte cells and the myelin sheaths they form," she said [9]. "Our research aims to understand the impact of these changes compared to the healthy nervous system as well as to find ways to promote myelin sheath growth in diseases where myelin is lost or damaged," she said [10].
I think the result, as reported, answers a clear developmental question. It explains why sheath length tracks axon width, a match the release ties to timing when nerve impulses arrive across brain circuits [11]. Whether Piezo1 becomes a repair target depends on whether the channel works the same way in adult lesions, where sheaths are already coming out too short [7].
What to watch
- The PLOS Biology methods: the species, whether axon or fiber width was varied on its own, and how much sheath length changes when Piezo1 is removed.
- Any study checking whether Piezo1 is active on oligodendrocytes rebuilding myelin in adult lesions, where sheaths come out short.
- Evidence that raising Piezo1 activity lengthens sheaths. A repair therapy would need it.